« Previous AbstractMaternal diabetes impairs oxidative and inflammatory response in murine placenta    Next AbstractEffect of mouth-rinse formulations on oral malodour processes in tongue-derived perfusion biofilm model »

Oral Dis

Title:		Comparative effects of various commercially available mouthrinse formulations on oral malodor
Author(s):		Saad S; Greenman J; Shaw H;
Address:		"Microbiology Unit, University of West of England, Bristol, UK"
Journal Title:		Oral Dis
Year:		2011
Volume:		17
Issue:		2
Page Number:		180 - 186
DOI:		10.1111/j.1601-0825.2010.01714.x
ISSN/ISBN:		1601-0825 (Electronic) 1354-523X (Linking)
Abstract:		"OBJECTIVES: The primary aim of this study was to compare a new mouthwash (SB12(R)) containing 0.025% chlorhexidine and 0.3% zinc for oral malodor reduction against four commercially available mouthwashes and negative control. A secondary aim was to compare the two methods for measuring volatile sulphur compounds (VSC) by halimetry and OralChroma. METHODS: Organoleptic scale, halimeter and the OralChroma were used to assess oral malodour and VSC. The effects of five test formulations and water (negative control) were assessed after 30, 60, 90 and 180 min, with 1 week between the treatments to avoid any cross-over effect. RESULTS: Reduction in H(2) S by halimetry and malodour levels by organoleptic assessment ranged from, slight (LacerFresh(R)) (P > 0.05), moderate (BreathRx(R), SmartMouth(R) (P < 0.01) to marked effects (SB12(R), Listerine(R)) (P < 0.001) at all time points compared with water. The largest differences were observed at 30 min and decreased with time. SB12(R) showed separation from Listerine(R) at 180 min, using ANOVA plus Bonferroni's Multiple Comparison post-test (P < 0.05). Relationships between organoleptic, halimeter and OralChroma were between R(2) = 0.795 and 0.926. CONCLUSION: SB12 shows a consistent and reproducible inhibitory effect on oral malodor parameters, which in turn correlate well with each other"
Keywords:		"Adult Anti-Infective Agents, Local/therapeutic use Benzoic Acid/therapeutic use Betaine/analogs & derivatives/therapeutic use Cetylpyridinium/therapeutic use Chemistry, Pharmaceutical Chlorhexidine/therapeutic use Double-Blind Method Drug Combinations Fem;"
Notes:		"MedlineSaad, S Greenman, J Shaw, H eng Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Denmark 2010/07/28 Oral Dis. 2011 Mar; 17(2):180-6. doi: 10.1111/j.1601-0825.2010.01714.x"